Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)
There is no proven preventative therapy or vaccine against COVID-19. Theinfection has spread rapidly and there has already been a substantial adverse impact on the global economy. Healthcare workers have been affected disproportionately in the continuing pandemic. Significant infection rates in this...
Hoofdauteurs: | Schilling, WHK, Callery, JJ, Taylor, W, Mukaka, M, Ekkapongpisit, M, Watson, JA, Chandna, A, Panapipat, S, Tubprasert, J, Yuentrakul, P, Waithira, N, Cope, T, Dhorda, M, Cruz, C, von Seidlein, L, Milton, J, LLewelyn, M, Adler, A, Chotivanich, K, Cheah, PY, Ashley, EA, Mayxay, M, Dondorp, AM, Phumratanaprapin, W, Day, NPJ, White, N |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
F1000 Research Ltd
2020
|
Gelijkaardige items
-
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
door: Schilling, WHK, et al.
Gepubliceerd in: (2024) -
Chloroquine, hydroxychloroquine and COVID-19
door: Erickson, T. B., et al.
Gepubliceerd in: (2020) -
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
door: White, NJ, et al.
Gepubliceerd in: (2020) -
Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine
door: Lotery, A, et al.
Gepubliceerd in: (2018) -
Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
door: Yusuf, IH, et al.
Gepubliceerd in: (2018)